Cencora Shares Outstanding 2010-2024 | COR
Cencora shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Cencora shares outstanding for the quarter ending June 30, 2024 were 0.200B, a 2.12% decline year-over-year.
- Cencora 2023 shares outstanding were 0.205B, a 3.13% decline from 2022.
- Cencora 2022 shares outstanding were 0.211B, a 1.32% increase from 2021.
- Cencora 2021 shares outstanding were 0.208B, a 1.8% increase from 2020.
| Cencora Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 205 |
| 2022 | 211 |
| 2021 | 208 |
| 2020 | 205 |
| 2019 | 212 |
| 2018 | 220 |
| 2017 | 222 |
| 2016 | 226 |
| 2015 | 218 |
| 2014 | 235 |
| 2013 | 235 |
| 2012 | 257 |
| 2011 | 278 |
| 2010 | 287 |
| 2009 | 303 |
| Cencora Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-06-30 | 200 |
| 2024-03-31 | 201 |
| 2023-12-31 | 202 |
| 2023-09-30 | 205 |
| 2023-06-30 | 204 |
| 2023-03-31 | 204 |
| 2022-12-31 | 206 |
| 2022-09-30 | 211 |
| 2022-06-30 | 212 |
| 2022-03-31 | 212 |
| 2021-12-31 | 211 |
| 2021-09-30 | 208 |
| 2021-06-30 | 209 |
| 2021-03-31 | 207 |
| 2020-12-31 | 207 |
| 2020-09-30 | 205 |
| 2020-06-30 | 206 |
| 2020-03-31 | 207 |
| 2019-12-31 | 208 |
| 2019-09-30 | 212 |
| 2019-06-30 | 211 |
| 2019-03-31 | 213 |
| 2018-12-31 | 214 |
| 2018-09-30 | 220 |
| 2018-06-30 | 221 |
| 2018-03-31 | 222 |
| 2017-12-31 | 221 |
| 2017-09-30 | 222 |
| 2017-06-30 | 222 |
| 2017-03-31 | 221 |
| 2016-12-31 | 222 |
| 2016-09-30 | 226 |
| 2016-06-30 | 225 |
| 2016-03-31 | 225 |
| 2015-12-31 | 227 |
| 2015-09-30 | 218 |
| 2015-06-30 | 240 |
| 2015-03-31 | 220 |
| 2014-12-31 | 219 |
| 2014-09-30 | 235 |
| 2014-06-30 | 226 |
| 2014-03-31 | 236 |
| 2013-12-31 | 237 |
| 2013-09-30 | 235 |
| 2013-06-30 | 236 |
| 2013-03-31 | 235 |
| 2012-12-31 | 236 |
| 2012-09-30 | 257 |
| 2012-06-30 | 256 |
| 2012-03-31 | 262 |
| 2011-12-31 | 263 |
| 2011-09-30 | 278 |
| 2011-06-30 | 279 |
| 2011-03-31 | 280 |
| 2010-12-31 | 281 |
| 2010-09-30 | 287 |
| 2010-06-30 | 287 |
| 2010-03-31 | 287 |
| 2009-12-31 | 291 |
| 2009-09-30 | 303 |
| 2009-06-30 | 301 |
| 2009-03-31 | 305 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $46.107B | $262.173B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.890B | 12.02 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| ICON (ICLR) | Ireland | $18.679B | 16.64 |
| Revvity (RVTY) | United States | $15.535B | 26.63 |
| Avantor (AVTR) | United States | $15.498B | 23.24 |
| Natera (NTRA) | United States | $15.385B | 0.00 |
| Viatris (VTRS) | United States | $13.858B | 4.22 |
| BioMerieux (BMXMF) | France | $13.601B | 0.00 |
| Solventum (SOLV) | United States | $12.636B | 0.00 |
| CochLear (CHEOY) | Australia | $12.565B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
| Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| HealthEquity (HQY) | United States | $7.792B | 42.29 |
| Doximity (DOCS) | United States | $7.787B | 49.34 |
| Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
| Life Times (LTH) | United States | $4.762B | 31.52 |
| PACS (PACS) | United States | $4.502B | 0.00 |
| Sotera Health (SHC) | United States | $4.367B | 23.36 |
| Organon (OGN) | United States | $4.239B | 4.28 |
| Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
| BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
| Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
| Concentras Parent (CON) | United States | $2.480B | 0.00 |
| Premier (PINC) | United States | $2.271B | 11.34 |
| GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
| GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.425B | 25.06 |
| Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
| CareDx (CDNA) | United States | $1.228B | 0.00 |
| Agilon Health (AGL) | United States | $1.123B | 0.00 |
| Embecta (EMBC) | United States | $0.864B | 5.76 |
| InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.722B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| DocGo (DCGO) | United States | $0.355B | 13.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
| ModivCare (MODV) | United States | $0.232B | 7.37 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Biodesix (BDSX) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
| MultiPlan (MPLN) | United States | $0.136B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.35 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.63 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.021B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |